The effect of low-dose human growth hormone [somatropin] therapy in HIV infected patients on highly active antiretroviral therapy (HAART)
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Somatrogon (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 08 Jul 2008 Status changed from active, no longer recruiting to completed.
- 26 Nov 2005 New trial record.